Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Top Buy

Security Buy Sell Buy (1W) ▼ Sell (1W) Price Target price Potential
Halozyme Therapeutics Inc. 15 0 1 0 €40.40 €47.17 16.757%
PTC Therapeutics Inc. 15 7 1 2 €33.80 €41.81 23.710%
Iovance Biotherapeutics Inc. 21 3 1 0 €9.20 €25.20 173.824%
United Therapeutics 19 0 1 0 €253.30 €287.40 13.463%
Xencor Inc. 10 1 0 0 €21.60 €32.58 50.828%
Charles River Labs Intl 10 0 0 0 €200.40 €248.57 24.037%
Exelixis Inc. 18 0 0 0 €18.58 €26.01 40.008%
Neurocrine Bioscience 29 0 0 0 €127.60 €140.60 10.191%
Catalent Inc. 1 0 0 0 €50.37 €55.00 9.192%
Repligen Corp. 13 0 0 0 €144.45 €184.76 27.906%
Emergent Biosolutions Inc. 2 3 0 0 €4.50 €4.62 2.577%
Nektar Therapeutics 3 1 0 0 €1.53 €3.70 141.357%
Agios Pharmaceuticals Inc. 6 0 0 0 €31.40 €38.99 24.168%
Medpace Holdings Inc 9 0 0 0 €361.70 €421.61 16.562%
Ultragenyx Pharmaceutical Inc. 17 1 0 0 €37.40 €84.74 126.588%
Novocure Ltd 1 1 0 0 €21.36 - -
Blueprint Medicines Corp 2 0 0 0 €93.68 - -
Arrowhead Pharmaceuticals Inc. 14 2 0 0 €22.94 €52.03 126.787%